NO20026244D0 - Neurobeskyttende 7-beta-hydroksysteroider - Google Patents

Neurobeskyttende 7-beta-hydroksysteroider

Info

Publication number
NO20026244D0
NO20026244D0 NO20026244A NO20026244A NO20026244D0 NO 20026244 D0 NO20026244 D0 NO 20026244D0 NO 20026244 A NO20026244 A NO 20026244A NO 20026244 A NO20026244 A NO 20026244A NO 20026244 D0 NO20026244 D0 NO 20026244D0
Authority
NO
Norway
Prior art keywords
hydroxysteroids
neuroprotective
beta
hydroxy
steroids
Prior art date
Application number
NO20026244A
Other languages
English (en)
Other versions
NO20026244L (no
NO332089B1 (no
Inventor
Ernst Wuelfert
Ashley Ker Pringle
Lars Eric Sundstrom
Original Assignee
Hunter Fleming Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter Fleming Ltd filed Critical Hunter Fleming Ltd
Publication of NO20026244D0 publication Critical patent/NO20026244D0/no
Publication of NO20026244L publication Critical patent/NO20026244L/no
Publication of NO332089B1 publication Critical patent/NO332089B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20026244A 2000-06-29 2002-12-27 Anvendelse av et 7ß-hydroksysteroid eller en farmasoytisk aksepterbar ester eller et annet derivat for fremstilling av et medikament for beskyttelse mot neuronskade NO332089B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0016027A GB2363984A (en) 2000-06-29 2000-06-29 Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids
PCT/GB2001/002929 WO2002000224A1 (en) 2000-06-29 2001-06-29 Neuroprotective 7-beta-hydroxysteroids

Publications (3)

Publication Number Publication Date
NO20026244D0 true NO20026244D0 (no) 2002-12-27
NO20026244L NO20026244L (no) 2003-02-27
NO332089B1 NO332089B1 (no) 2012-06-18

Family

ID=9894710

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026244A NO332089B1 (no) 2000-06-29 2002-12-27 Anvendelse av et 7ß-hydroksysteroid eller en farmasoytisk aksepterbar ester eller et annet derivat for fremstilling av et medikament for beskyttelse mot neuronskade

Country Status (23)

Country Link
US (2) US20030186953A1 (no)
EP (1) EP1294381B1 (no)
JP (1) JP2004501195A (no)
KR (1) KR100829490B1 (no)
CN (1) CN100441189C (no)
AT (1) ATE303152T1 (no)
AU (2) AU2001267705B2 (no)
CA (1) CA2414583C (no)
CY (1) CY1105371T1 (no)
CZ (1) CZ305306B6 (no)
DE (1) DE60113112T2 (no)
DK (1) DK1294381T3 (no)
ES (1) ES2247141T3 (no)
GB (1) GB2363984A (no)
HK (1) HK1052299B (no)
HU (1) HU229265B1 (no)
IL (2) IL153540A0 (no)
NO (1) NO332089B1 (no)
PL (1) PL200698B1 (no)
RU (1) RU2258511C2 (no)
SI (1) SI1294381T1 (no)
WO (1) WO2002000224A1 (no)
ZA (1) ZA200210214B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
GB2378898A (en) * 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
EP1539183A4 (en) * 2002-08-28 2007-04-25 Hollis Eden Pharmaceuticals THERAPEUTIC TREATMENT METHODS
US20070231373A1 (en) * 2004-04-28 2007-10-04 Hunter-Fleming Limited Transdermal Steriod for Formulation
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses
EP1827422A2 (en) * 2004-11-23 2007-09-05 Celgene Corporation Jnk inhibitors for the treatment of cns injury
JP5386362B2 (ja) 2006-11-21 2014-01-15 ウメクライン アーベー Ｃｎｓ疾患治療用医薬組成物の製造のためのプレグナンおよびアンドロスタンステロイドの使用
KR20090086272A (ko) 2006-11-30 2009-08-11 헌터-플레밍 리미티드 프로스타글란딘／시클로옥시게나제 대사 경로의 조절
GB0623971D0 (en) * 2006-11-30 2007-01-10 Hunter Fleming Ltd Modulation of prostaglandin/cyclooxygenase metabolic pathways
CZ2008434A3 (cs) * 2008-07-10 2009-12-09 Ústav organické chemie a biochemie Akademie ved CR, v. v. i. Pregnanové anionické slouceniny, zpusob jejich výroby a jejich použití
CU20110244A7 (es) 2011-12-27 2013-08-29 Ct De Investigación Y Desarrollo De Medicamentos Cidem Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios
DE102012001361A1 (de) 2012-01-24 2013-07-25 Linde Aktiengesellschaft Verfahren zum Kaltgasspritzen
US20160362442A1 (en) * 2015-06-10 2016-12-15 IronMag Labs Method For DHEA Enanthate Processing

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292730A (en) * 1990-08-29 1994-03-08 Humanetics Corporation Modulation of immune system with Δ5-androstenes
FR2696934B1 (fr) * 1992-10-20 1995-06-02 Conservatoire Nal Arts Metiers Dérivés de stéroïdes naturels 3B hydroxyles ayant des propriétés de déclenchement et de stimulation de l'immunité, composition les contenant et procédé pour les obtenir.
ES2229215T3 (es) * 1993-03-09 2005-04-16 University Of Utah Research Foundation Uso de dhea y derivados de la misma para la preparacion de un medicamento para la prevencion de necrosis progresiva, lesion por reperfusion , transpoosicion bacteriana y sindrome de insuficiencia respiratoria del adulto.
WO1996040043A2 (en) * 1995-06-06 1996-12-19 Cocensys, Inc. Neuroactive steroids of the androstane and pregnane series
GB2317826B (en) * 1995-08-29 1999-12-15 Univ Edinburgh Regulation of intracellular glucocorticoid concentrations
US5985242A (en) * 1995-10-27 1999-11-16 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
EP0954317B1 (en) * 1996-04-09 2007-06-06 The University Of Edinburgh Use of 7 apha-substituted steroids to treat neuropsychiatric disorders
CN1222851A (zh) * 1996-04-09 1999-07-14 英国技术集团国际有限公司 7α－取代的类固醇用于治疗神经精神病、免疫或内分泌疾病的用途
ATE298765T1 (de) * 1996-08-27 2005-07-15 Praecis Pharm Inc Beta-amyloid peptidaggregation regulierende peptide mit d-aminosäuren
WO1999015179A1 (en) * 1997-09-25 1999-04-01 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
AU1387399A (en) * 1997-11-10 1999-05-31 Vyrex Corporation Probucol esters and uses thereof
EP1032397A1 (en) * 1997-11-24 2000-09-06 University Of Florida Research Foundation, Inc. Testosterone inhibitors and use for the protection of neurons
WO1999052532A1 (en) * 1998-04-14 1999-10-21 Pharmadigm, Inc. Method for reducing central nervous system impairment
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
DK1226155T3 (da) * 1999-11-02 2007-09-10 Bayer Schering Pharma Ag 18-nor-steroider som selektivt virksomme östrogener
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone

Also Published As

Publication number Publication date
EP1294381A1 (en) 2003-03-26
NO20026244L (no) 2003-02-27
US20100130459A1 (en) 2010-05-27
GB2363984A (en) 2002-01-16
PL200698B1 (pl) 2009-01-30
CN1443071A (zh) 2003-09-17
IL153540A (en) 2008-07-08
DK1294381T3 (da) 2005-10-31
AU6770501A (en) 2002-01-08
RU2258511C2 (ru) 2005-08-20
KR100829490B1 (ko) 2008-05-16
CZ305306B6 (cs) 2015-07-22
EP1294381B1 (en) 2005-08-31
ZA200210214B (en) 2004-03-17
CA2414583C (en) 2010-08-24
CN100441189C (zh) 2008-12-10
US20030186953A1 (en) 2003-10-02
CA2414583A1 (en) 2002-01-03
HU229265B1 (en) 2013-10-28
HUP0301317A2 (hu) 2003-08-28
KR20030034112A (ko) 2003-05-01
GB0016027D0 (en) 2000-08-23
CY1105371T1 (el) 2010-04-28
NO332089B1 (no) 2012-06-18
JP2004501195A (ja) 2004-01-15
HK1052299B (zh) 2006-01-27
PL359105A1 (en) 2004-08-23
DE60113112T2 (de) 2006-07-13
ES2247141T3 (es) 2006-03-01
DE60113112D1 (de) 2005-10-06
ATE303152T1 (de) 2005-09-15
HK1052299A1 (en) 2003-09-11
HUP0301317A3 (en) 2006-06-28
SI1294381T1 (sl) 2006-04-30
AU2001267705B2 (en) 2005-08-18
IL153540A0 (en) 2003-07-06
WO2002000224A1 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
CY1105371T1 (el) Νευροπροστατευτικα 7-βητα-υδροξυστepοειδη
LU92745I2 (fr) Nétupitant/Palonosétron et leurs dérivés pharmaceutiquement acceptables (AKYNZEOr)
LU92381I2 (fr) Macitentan et ses dérivés pharmaceutiquement acceptables (OPSUMIT)
NO20020275D0 (no) Imidazoimidazoler og -triazoler som anti-inflammatoriske midler
LU91501I2 (fr) Sugammadex et ses sels pharmaceutiquement acceptables-BRIDION
PL120714U1 (pl) Urzadzenie ochronne sluchu w postaci zwinietej do dystrybucji
DE60231189D1 (de) Ng sowie plasmaanzeigevorrichtung
AU2003265576A8 (en) Corticosteroid conjugates and uses thereof
DE60312950D1 (de) Gaseinführungs- und -verteilungschlauch
AU3672600A (en) Stage device and exposure device
AU2002234773A1 (en) Pharmaceutically effective ginsenosides and their use
ATE401897T1 (de) 7-hydroxyepiandrosteron mit neuroprotektiver wirkung
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2003281491A1 (en) Protection pad for the tochantheric region and device comprising the pad
AU2001291877A1 (en) N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent againstparasitic protozoans
DE60045605D1 (de) Transformator,Lautsprechervorrichtung und Lautsprechersystem
AU7577100A (en) Thionin as an antineoplastic and immunostimulant
DE60036356D1 (de) Düse sowie zugehöriger Absauger
AU2002222093A1 (en) Goggles and masks
AU2002327431A1 (en) Reticle protection and transport
AU2001267827A1 (en) Anti-inflammatory and analgesic agents
AU2003302861A1 (en) Testing and protection device for telephone lines
NZ524962A (en) Thionin as an antineoplastic and immunostimulant
AU2002342620A1 (en) Copy protection device

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees